| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Rett Syndrome | 76 | 2025 | 293 | 11.090 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 40 | 2025 | 309 | 3.140 |
Why?
|
| Prader-Willi Syndrome | 5 | 2022 | 70 | 1.760 |
Why?
|
| Electroencephalography | 27 | 2025 | 908 | 1.200 |
Why?
|
| Angelman Syndrome | 6 | 2022 | 72 | 1.160 |
Why?
|
| Sleep Wake Disorders | 7 | 2022 | 197 | 1.140 |
Why?
|
| Child | 105 | 2025 | 25761 | 1.040 |
Why?
|
| Sleep | 10 | 2022 | 374 | 1.010 |
Why?
|
| Epilepsy | 7 | 2022 | 889 | 0.990 |
Why?
|
| Polysomnography | 8 | 2022 | 155 | 0.980 |
Why?
|
| Growth Disorders | 8 | 2012 | 191 | 0.950 |
Why?
|
| Sleep Apnea Syndromes | 2 | 2022 | 83 | 0.940 |
Why?
|
| Neurodevelopmental Disorders | 2 | 2021 | 560 | 0.940 |
Why?
|
| Child, Preschool | 79 | 2025 | 14732 | 0.940 |
Why?
|
| Adolescent | 80 | 2025 | 20535 | 0.900 |
Why?
|
| Glutamates | 5 | 2023 | 69 | 0.880 |
Why?
|
| Bone Density | 3 | 2014 | 367 | 0.810 |
Why?
|
| Mutation | 25 | 2023 | 6226 | 0.790 |
Why?
|
| Scoliosis | 5 | 2018 | 143 | 0.700 |
Why?
|
| Disorders of Excessive Somnolence | 3 | 2022 | 43 | 0.630 |
Why?
|
| Humans | 151 | 2025 | 131924 | 0.610 |
Why?
|
| Female | 106 | 2025 | 70584 | 0.600 |
Why?
|
| Spasms, Infantile | 11 | 1994 | 175 | 0.590 |
Why?
|
| Glutamic Acid | 1 | 2019 | 209 | 0.560 |
Why?
|
| Folic Acid | 3 | 2010 | 288 | 0.520 |
Why?
|
| Oligopeptides | 1 | 2017 | 116 | 0.520 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2019 | 305 | 0.520 |
Why?
|
| Gastrointestinal Diseases | 4 | 2023 | 357 | 0.510 |
Why?
|
| Osteocalcin | 2 | 2014 | 46 | 0.500 |
Why?
|
| Infant | 50 | 2023 | 13047 | 0.500 |
Why?
|
| Alkaline Phosphatase | 2 | 2014 | 97 | 0.500 |
Why?
|
| Severity of Illness Index | 15 | 2021 | 3087 | 0.480 |
Why?
|
| Neuroprotective Agents | 1 | 2017 | 161 | 0.480 |
Why?
|
| Young Adult | 24 | 2025 | 9952 | 0.470 |
Why?
|
| Gastrectomy | 1 | 2016 | 102 | 0.470 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 5 | 2012 | 101 | 0.450 |
Why?
|
| Collagen Type I | 1 | 2014 | 121 | 0.430 |
Why?
|
| Autonomic Nervous System | 2 | 2005 | 49 | 0.410 |
Why?
|
| Phenotype | 18 | 2024 | 4526 | 0.410 |
Why?
|
| Osteogenesis | 1 | 2014 | 163 | 0.410 |
Why?
|
| Double-Blind Method | 9 | 2023 | 1656 | 0.400 |
Why?
|
| Autistic Disorder | 7 | 2009 | 386 | 0.400 |
Why?
|
| Nutrition Disorders | 1 | 2012 | 29 | 0.390 |
Why?
|
| Betaine | 2 | 2010 | 21 | 0.390 |
Why?
|
| Adult | 40 | 2025 | 31536 | 0.380 |
Why?
|
| Cerebral Cortex | 5 | 2005 | 480 | 0.380 |
Why?
|
| Vitamin D | 2 | 2011 | 183 | 0.370 |
Why?
|
| Bone and Bones | 1 | 2014 | 301 | 0.370 |
Why?
|
| Quality of Life | 10 | 2022 | 2157 | 0.370 |
Why?
|
| Caregivers | 5 | 2023 | 588 | 0.360 |
Why?
|
| Prevalence | 10 | 2019 | 2658 | 0.360 |
Why?
|
| Age Factors | 15 | 2020 | 2912 | 0.360 |
Why?
|
| Dietary Supplements | 2 | 2011 | 439 | 0.350 |
Why?
|
| Calcium, Dietary | 2 | 2014 | 38 | 0.350 |
Why?
|
| Vitamins | 1 | 2011 | 112 | 0.350 |
Why?
|
| Male | 55 | 2025 | 64870 | 0.340 |
Why?
|
| Chromosome Duplication | 3 | 2020 | 149 | 0.340 |
Why?
|
| Peptides | 1 | 2014 | 846 | 0.340 |
Why?
|
| Vitamin D Deficiency | 1 | 2011 | 74 | 0.340 |
Why?
|
| Parents | 5 | 2024 | 1079 | 0.340 |
Why?
|
| Surveys and Questionnaires | 10 | 2024 | 3990 | 0.330 |
Why?
|
| Gene Duplication | 5 | 2024 | 369 | 0.320 |
Why?
|
| Tourette Syndrome | 4 | 2008 | 158 | 0.320 |
Why?
|
| Growth | 1 | 2009 | 95 | 0.300 |
Why?
|
| Body Size | 1 | 2009 | 68 | 0.300 |
Why?
|
| Nutritional Support | 1 | 2009 | 55 | 0.300 |
Why?
|
| Attention | 2 | 2008 | 199 | 0.300 |
Why?
|
| Gastrostomy | 1 | 2009 | 92 | 0.290 |
Why?
|
| Somnambulism | 1 | 2008 | 3 | 0.290 |
Why?
|
| Night Terrors | 1 | 2008 | 3 | 0.290 |
Why?
|
| Regression Analysis | 4 | 2011 | 795 | 0.280 |
Why?
|
| Mathematics | 1 | 2008 | 85 | 0.280 |
Why?
|
| Human Growth Hormone | 1 | 2008 | 75 | 0.270 |
Why?
|
| Epilepsies, Partial | 6 | 2006 | 95 | 0.270 |
Why?
|
| Neuropsychological Tests | 6 | 2020 | 989 | 0.270 |
Why?
|
| Brain | 9 | 2005 | 3175 | 0.260 |
Why?
|
| Adrenocorticotropic Hormone | 6 | 1994 | 74 | 0.260 |
Why?
|
| Fractures, Bone | 1 | 2008 | 205 | 0.250 |
Why?
|
| Cognition | 3 | 2008 | 810 | 0.250 |
Why?
|
| Longitudinal Studies | 8 | 2019 | 1499 | 0.240 |
Why?
|
| Psychometrics | 4 | 2024 | 686 | 0.240 |
Why?
|
| Evoked Potentials, Somatosensory | 1 | 2005 | 37 | 0.240 |
Why?
|
| Tetrahydrofolates | 1 | 2005 | 17 | 0.240 |
Why?
|
| Intestinal Absorption | 1 | 2006 | 176 | 0.230 |
Why?
|
| Absorptiometry, Photon | 3 | 2014 | 203 | 0.230 |
Why?
|
| Body Composition | 1 | 2008 | 550 | 0.230 |
Why?
|
| Cerebrospinal Fluid | 1 | 2005 | 98 | 0.230 |
Why?
|
| Chromosomes, Human, X | 4 | 2023 | 157 | 0.220 |
Why?
|
| Nutritional Status | 2 | 2011 | 294 | 0.210 |
Why?
|
| Treatment Outcome | 10 | 2024 | 12991 | 0.210 |
Why?
|
| Walking | 3 | 2022 | 234 | 0.210 |
Why?
|
| Anticonvulsants | 4 | 2015 | 389 | 0.210 |
Why?
|
| Intellectual Disability | 7 | 2009 | 1086 | 0.200 |
Why?
|
| Prospective Studies | 12 | 2025 | 6569 | 0.200 |
Why?
|
| Abnormalities, Multiple | 6 | 2019 | 981 | 0.190 |
Why?
|
| Epilepsy, Frontal Lobe | 1 | 2002 | 10 | 0.190 |
Why?
|
| Narcolepsy | 1 | 2022 | 6 | 0.190 |
Why?
|
| Epilepsy, Temporal Lobe | 2 | 2002 | 91 | 0.190 |
Why?
|
| Epilepsy, Generalized | 2 | 2006 | 65 | 0.190 |
Why?
|
| Chromosomes, Human, Pair 17 | 6 | 2007 | 372 | 0.180 |
Why?
|
| Anti-Anxiety Agents | 1 | 2022 | 77 | 0.180 |
Why?
|
| Cognition Disorders | 2 | 2018 | 568 | 0.180 |
Why?
|
| Evidence-Based Medicine | 1 | 2005 | 662 | 0.180 |
Why?
|
| Hand | 2 | 2019 | 106 | 0.180 |
Why?
|
| Psychomotor Performance | 1 | 2002 | 182 | 0.170 |
Why?
|
| Reproducibility of Results | 4 | 2024 | 3011 | 0.170 |
Why?
|
| Sleep Apnea, Obstructive | 2 | 2020 | 234 | 0.170 |
Why?
|
| Calcium | 1 | 2006 | 1078 | 0.170 |
Why?
|
| Child Behavior | 2 | 2020 | 236 | 0.170 |
Why?
|
| Gray Matter | 1 | 2020 | 44 | 0.160 |
Why?
|
| Motor Activity | 2 | 2020 | 523 | 0.160 |
Why?
|
| Hypnotics and Sedatives | 3 | 2007 | 136 | 0.160 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2020 | 79 | 0.160 |
Why?
|
| Retrospective Studies | 10 | 2019 | 17374 | 0.160 |
Why?
|
| X Chromosome | 3 | 2004 | 340 | 0.160 |
Why?
|
| Body Mass Index | 6 | 2018 | 1696 | 0.160 |
Why?
|
| Gastroesophageal Reflux | 1 | 2023 | 338 | 0.160 |
Why?
|
| Stereotyped Behavior | 2 | 2019 | 38 | 0.160 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2017 | 1672 | 0.160 |
Why?
|
| Esophageal Motility Disorders | 1 | 1999 | 22 | 0.150 |
Why?
|
| Cross-Sectional Studies | 6 | 2018 | 3760 | 0.150 |
Why?
|
| Oropharynx | 1 | 1999 | 36 | 0.150 |
Why?
|
| Biliary Tract Diseases | 1 | 2019 | 37 | 0.150 |
Why?
|
| Rare Diseases | 1 | 2021 | 209 | 0.150 |
Why?
|
| Parathyroid Hormone | 2 | 2011 | 83 | 0.150 |
Why?
|
| Chromosome Aberrations | 4 | 2011 | 589 | 0.150 |
Why?
|
| Health Status | 1 | 2021 | 407 | 0.150 |
Why?
|
| Gastrointestinal Tract | 1 | 2021 | 232 | 0.150 |
Why?
|
| Proportional Hazards Models | 3 | 2017 | 1458 | 0.140 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2016 | 1127 | 0.140 |
Why?
|
| Prednisone | 4 | 1991 | 253 | 0.140 |
Why?
|
| Metabolome | 1 | 2021 | 325 | 0.140 |
Why?
|
| Respiration Disorders | 1 | 2018 | 33 | 0.140 |
Why?
|
| Organ Size | 2 | 2020 | 447 | 0.140 |
Why?
|
| White Matter | 1 | 2020 | 213 | 0.140 |
Why?
|
| Repressor Proteins | 2 | 2018 | 812 | 0.140 |
Why?
|
| Seizures | 4 | 2018 | 893 | 0.140 |
Why?
|
| Pilot Projects | 1 | 2022 | 1440 | 0.130 |
Why?
|
| Energy Metabolism | 3 | 1998 | 785 | 0.130 |
Why?
|
| Chromosome Disorders | 1 | 2019 | 311 | 0.130 |
Why?
|
| Ataxia | 3 | 1987 | 177 | 0.130 |
Why?
|
| Puberty | 2 | 2014 | 104 | 0.130 |
Why?
|
| Urinary Retention | 1 | 2016 | 19 | 0.130 |
Why?
|
| Diet | 2 | 2014 | 1125 | 0.120 |
Why?
|
| Urethral Obstruction | 1 | 2016 | 58 | 0.120 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2018 | 323 | 0.120 |
Why?
|
| Pediatrics | 1 | 2005 | 1211 | 0.120 |
Why?
|
| Age of Onset | 3 | 2015 | 622 | 0.120 |
Why?
|
| Middle Aged | 13 | 2022 | 28943 | 0.120 |
Why?
|
| Cohort Studies | 3 | 2017 | 5163 | 0.120 |
Why?
|
| Gene Dosage | 2 | 2007 | 449 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 15 | 3 | 2011 | 147 | 0.110 |
Why?
|
| Sodium Channel Blockers | 1 | 2015 | 24 | 0.110 |
Why?
|
| Monitoring, Physiologic | 4 | 1994 | 377 | 0.110 |
Why?
|
| Phosphorus, Dietary | 1 | 2014 | 4 | 0.110 |
Why?
|
| Diet Records | 1 | 2014 | 71 | 0.110 |
Why?
|
| Body Height | 4 | 2012 | 204 | 0.110 |
Why?
|
| Predictive Value of Tests | 3 | 2017 | 2311 | 0.110 |
Why?
|
| Renal Insufficiency | 1 | 2016 | 256 | 0.110 |
Why?
|
| Population Surveillance | 2 | 1995 | 416 | 0.110 |
Why?
|
| Dementia | 3 | 1987 | 458 | 0.100 |
Why?
|
| Obesity, Morbid | 1 | 2016 | 210 | 0.100 |
Why?
|
| Forkhead Transcription Factors | 1 | 2016 | 381 | 0.100 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2021 | 810 | 0.100 |
Why?
|
| Follow-Up Studies | 7 | 2019 | 5408 | 0.100 |
Why?
|
| Sleep Stages | 3 | 2008 | 34 | 0.100 |
Why?
|
| Biomarkers | 3 | 2014 | 3404 | 0.100 |
Why?
|
| Dietary Proteins | 1 | 2014 | 219 | 0.100 |
Why?
|
| Tetrabenazine | 3 | 1988 | 41 | 0.100 |
Why?
|
| Infant Nutrition Disorders | 1 | 2012 | 15 | 0.100 |
Why?
|
| Prognosis | 4 | 2019 | 5007 | 0.090 |
Why?
|
| Genotype | 4 | 2018 | 2696 | 0.090 |
Why?
|
| Child Nutrition Disorders | 1 | 2012 | 42 | 0.090 |
Why?
|
| Bone Diseases | 1 | 2012 | 46 | 0.090 |
Why?
|
| Critical Pathways | 1 | 2012 | 75 | 0.090 |
Why?
|
| Databases, Factual | 2 | 2016 | 1228 | 0.090 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2012 | 82 | 0.090 |
Why?
|
| Nuclear Proteins | 1 | 2018 | 1280 | 0.090 |
Why?
|
| Constipation | 2 | 2023 | 128 | 0.090 |
Why?
|
| Child Behavior Disorders | 1 | 2012 | 70 | 0.090 |
Why?
|
| Dairy Products | 1 | 2011 | 44 | 0.090 |
Why?
|
| Movement Disorders | 3 | 1998 | 223 | 0.090 |
Why?
|
| Health Surveys | 1 | 2012 | 259 | 0.090 |
Why?
|
| Anxiety | 3 | 2022 | 991 | 0.090 |
Why?
|
| Case-Control Studies | 5 | 2020 | 3409 | 0.090 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2011 | 375 | 0.090 |
Why?
|
| Substance P | 2 | 2001 | 35 | 0.090 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2015 | 481 | 0.090 |
Why?
|
| Laparoscopy | 1 | 2016 | 523 | 0.090 |
Why?
|
| Body Weight | 4 | 2012 | 994 | 0.080 |
Why?
|
| Point Mutation | 2 | 2004 | 348 | 0.080 |
Why?
|
| Homovanillic Acid | 2 | 2009 | 28 | 0.080 |
Why?
|
| Hydroxyindoleacetic Acid | 2 | 2009 | 30 | 0.080 |
Why?
|
| Evoked Potentials | 3 | 2002 | 121 | 0.080 |
Why?
|
| Sleep, REM | 7 | 2014 | 23 | 0.080 |
Why?
|
| Sex Factors | 2 | 2010 | 1351 | 0.080 |
Why?
|
| Apnea | 3 | 1986 | 31 | 0.080 |
Why?
|
| Nerve Tissue Proteins | 1 | 2016 | 1131 | 0.080 |
Why?
|
| Amines | 1 | 2009 | 38 | 0.080 |
Why?
|
| Body Fluid Compartments | 1 | 2009 | 19 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 1990 | 94 | 0.080 |
Why?
|
| Registries | 2 | 1995 | 1579 | 0.080 |
Why?
|
| Biomechanical Phenomena | 2 | 2020 | 229 | 0.080 |
Why?
|
| Respiration | 2 | 1987 | 123 | 0.080 |
Why?
|
| Analysis of Variance | 2 | 2008 | 1011 | 0.080 |
Why?
|
| Syndrome | 7 | 2007 | 1174 | 0.080 |
Why?
|
| Gait | 2 | 2020 | 142 | 0.080 |
Why?
|
| Terminology as Topic | 1 | 2010 | 232 | 0.070 |
Why?
|
| Fundoplication | 1 | 2009 | 70 | 0.070 |
Why?
|
| Exercise Test | 2 | 2020 | 258 | 0.070 |
Why?
|
| Infant, Newborn | 8 | 2010 | 8542 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2010 | 3351 | 0.070 |
Why?
|
| Disease Progression | 4 | 2019 | 2221 | 0.070 |
Why?
|
| Long QT Syndrome | 2 | 2015 | 86 | 0.070 |
Why?
|
| Translocation, Genetic | 1 | 1990 | 356 | 0.070 |
Why?
|
| Anxiety Disorders | 1 | 2014 | 720 | 0.070 |
Why?
|
| DNA Methylation | 2 | 2011 | 1122 | 0.070 |
Why?
|
| HLA Antigens | 1 | 1988 | 218 | 0.070 |
Why?
|
| Child Abuse | 2 | 1988 | 204 | 0.070 |
Why?
|
| Immersion | 1 | 1987 | 8 | 0.070 |
Why?
|
| Brain Diseases | 2 | 1987 | 305 | 0.060 |
Why?
|
| Adaptation, Psychological | 2 | 2017 | 451 | 0.060 |
Why?
|
| Calcium Isotopes | 1 | 2006 | 3 | 0.060 |
Why?
|
| Adipose Tissue | 1 | 2009 | 504 | 0.060 |
Why?
|
| Drowning | 1 | 1987 | 46 | 0.060 |
Why?
|
| Pyridines | 1 | 2007 | 249 | 0.060 |
Why?
|
| Cytokines | 1 | 2012 | 1359 | 0.060 |
Why?
|
| Reference Values | 2 | 2005 | 704 | 0.060 |
Why?
|
| Phosphorus | 1 | 2006 | 61 | 0.060 |
Why?
|
| Afferent Pathways | 1 | 2005 | 15 | 0.060 |
Why?
|
| Sequence Deletion | 2 | 2005 | 526 | 0.060 |
Why?
|
| DNA Copy Number Variations | 2 | 2024 | 1032 | 0.060 |
Why?
|
| Diagnosis, Differential | 2 | 2008 | 1949 | 0.060 |
Why?
|
| Behavior | 2 | 2002 | 74 | 0.060 |
Why?
|
| Anthropometry | 3 | 2022 | 194 | 0.060 |
Why?
|
| Leucovorin | 1 | 2005 | 54 | 0.060 |
Why?
|
| Carbamazepine | 3 | 1995 | 47 | 0.060 |
Why?
|
| Respiratory Mechanics | 1 | 2005 | 79 | 0.060 |
Why?
|
| Folic Acid Deficiency | 1 | 2005 | 51 | 0.060 |
Why?
|
| Hydrocortisone | 1 | 2006 | 226 | 0.060 |
Why?
|
| Texas | 3 | 2008 | 3627 | 0.060 |
Why?
|
| Databases, Genetic | 1 | 2007 | 501 | 0.060 |
Why?
|
| Trisomy | 1 | 2005 | 112 | 0.060 |
Why?
|
| Developmental Disabilities | 2 | 2006 | 755 | 0.060 |
Why?
|
| Risk Factors | 5 | 2019 | 10933 | 0.060 |
Why?
|
| Memory | 2 | 2012 | 356 | 0.060 |
Why?
|
| Exons | 2 | 2005 | 804 | 0.050 |
Why?
|
| Chromosome Deletion | 2 | 2006 | 654 | 0.050 |
Why?
|
| Blood-Brain Barrier | 1 | 2005 | 156 | 0.050 |
Why?
|
| Creatinine | 1 | 2006 | 412 | 0.050 |
Why?
|
| Genetic Heterogeneity | 1 | 2024 | 140 | 0.050 |
Why?
|
| Adenoidectomy | 1 | 2005 | 85 | 0.050 |
Why?
|
| Sudden Infant Death | 1 | 1984 | 36 | 0.050 |
Why?
|
| Gene Expression | 2 | 2016 | 1558 | 0.050 |
Why?
|
| DNA-Binding Proteins | 2 | 2004 | 1978 | 0.050 |
Why?
|
| Mosaicism | 1 | 2005 | 249 | 0.050 |
Why?
|
| Drug Administration Schedule | 3 | 2007 | 749 | 0.050 |
Why?
|
| Heterozygote | 1 | 2006 | 713 | 0.050 |
Why?
|
| Tyrosine 3-Monooxygenase | 3 | 2009 | 53 | 0.050 |
Why?
|
| Biogenic Amines | 3 | 1989 | 20 | 0.050 |
Why?
|
| Tonsillectomy | 1 | 2005 | 110 | 0.050 |
Why?
|
| Neurons | 3 | 2009 | 1998 | 0.050 |
Why?
|
| Arousal | 1 | 1983 | 80 | 0.050 |
Why?
|
| Electrocardiography | 2 | 2002 | 1000 | 0.050 |
Why?
|
| Socialization | 1 | 2002 | 17 | 0.050 |
Why?
|
| Heart Rate | 1 | 2005 | 584 | 0.050 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2004 | 199 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2005 | 1044 | 0.050 |
Why?
|
| Mental Disorders | 1 | 2009 | 888 | 0.050 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2022 | 83 | 0.050 |
Why?
|
| Digestive System | 1 | 2001 | 65 | 0.040 |
Why?
|
| Enteric Nervous System | 1 | 2001 | 43 | 0.040 |
Why?
|
| Brain Chemistry | 2 | 2000 | 116 | 0.040 |
Why?
|
| Behavior Therapy | 1 | 2004 | 269 | 0.040 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2021 | 67 | 0.040 |
Why?
|
| Standard of Care | 1 | 2022 | 134 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 2 | 1987 | 2166 | 0.040 |
Why?
|
| Videotape Recording | 2 | 1993 | 58 | 0.040 |
Why?
|
| In Situ Hybridization, Fluorescence | 4 | 2007 | 768 | 0.040 |
Why?
|
| Dosage Compensation, Genetic | 1 | 2000 | 59 | 0.040 |
Why?
|
| Schools | 1 | 2002 | 236 | 0.040 |
Why?
|
| Melatonin | 1 | 2000 | 30 | 0.040 |
Why?
|
| Mice | 4 | 2016 | 18460 | 0.040 |
Why?
|
| Alleles | 1 | 2024 | 1684 | 0.040 |
Why?
|
| HIV Infections | 1 | 2012 | 2035 | 0.040 |
Why?
|
| Activities of Daily Living | 1 | 2002 | 428 | 0.040 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2021 | 394 | 0.040 |
Why?
|
| Aged | 4 | 2019 | 21385 | 0.040 |
Why?
|
| Video Recording | 2 | 2006 | 204 | 0.040 |
Why?
|
| Gastric Emptying | 1 | 1999 | 79 | 0.040 |
Why?
|
| Deglutition | 1 | 1999 | 60 | 0.040 |
Why?
|
| Energy Intake | 2 | 1999 | 493 | 0.040 |
Why?
|
| Wakefulness | 3 | 1991 | 104 | 0.040 |
Why?
|
| Cost of Illness | 1 | 2020 | 284 | 0.040 |
Why?
|
| Clinical Trials as Topic | 4 | 2006 | 1161 | 0.040 |
Why?
|
| Primary Health Care | 1 | 2005 | 793 | 0.040 |
Why?
|
| Child Development | 4 | 1991 | 271 | 0.040 |
Why?
|
| North America | 2 | 2010 | 265 | 0.040 |
Why?
|
| Munchausen Syndrome | 2 | 1988 | 4 | 0.030 |
Why?
|
| Animals | 5 | 2016 | 34781 | 0.030 |
Why?
|
| Movement | 1 | 2019 | 168 | 0.030 |
Why?
|
| Communication | 1 | 2002 | 542 | 0.030 |
Why?
|
| Chromosome Banding | 2 | 2005 | 140 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2020 | 3829 | 0.030 |
Why?
|
| Foot | 1 | 1998 | 64 | 0.030 |
Why?
|
| Circadian Rhythm | 1 | 2000 | 317 | 0.030 |
Why?
|
| Feces | 1 | 2021 | 755 | 0.030 |
Why?
|
| Television | 1 | 1998 | 71 | 0.030 |
Why?
|
| Phenytoin | 2 | 2015 | 59 | 0.030 |
Why?
|
| Linear Models | 2 | 2016 | 713 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2022 | 1246 | 0.030 |
Why?
|
| Dominance, Cerebral | 2 | 1994 | 55 | 0.030 |
Why?
|
| Penetrance | 1 | 2016 | 113 | 0.030 |
Why?
|
| Reaction Time | 2 | 1987 | 167 | 0.030 |
Why?
|
| Signal Processing, Computer-Assisted | 2 | 1994 | 131 | 0.030 |
Why?
|
| Radiation Protection | 2 | 1973 | 58 | 0.030 |
Why?
|
| Incidence | 2 | 1995 | 3375 | 0.030 |
Why?
|
| Species Specificity | 1 | 2016 | 541 | 0.030 |
Why?
|
| Hydrotherapy | 1 | 1995 | 4 | 0.030 |
Why?
|
| Hypnosis | 1 | 1995 | 13 | 0.030 |
Why?
|
| Hyperventilation | 1 | 2015 | 14 | 0.030 |
Why?
|
| Alpha Rhythm | 1 | 1995 | 9 | 0.030 |
Why?
|
| Calibration | 1 | 2015 | 99 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2021 | 1799 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2016 | 4680 | 0.030 |
Why?
|
| Brain Stem | 3 | 2000 | 119 | 0.030 |
Why?
|
| Physical Therapy Modalities | 1 | 1995 | 56 | 0.030 |
Why?
|
| Propranolol | 1 | 2015 | 112 | 0.030 |
Why?
|
| Menarche | 1 | 2014 | 35 | 0.030 |
Why?
|
| United States | 2 | 2023 | 11648 | 0.030 |
Why?
|
| Radiation Dosage | 2 | 1978 | 146 | 0.030 |
Why?
|
| Emotions | 1 | 2017 | 367 | 0.030 |
Why?
|
| Death, Sudden | 1 | 1994 | 47 | 0.030 |
Why?
|
| Tomography, X-Ray | 1 | 1973 | 3 | 0.030 |
Why?
|
| Thermoluminescent Dosimetry | 1 | 1973 | 11 | 0.030 |
Why?
|
| Naltrexone | 1 | 1994 | 71 | 0.030 |
Why?
|
| Chromosome Mapping | 2 | 2007 | 1095 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 1994 | 243 | 0.030 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2015 | 224 | 0.030 |
Why?
|
| Delayed Diagnosis | 1 | 2015 | 133 | 0.030 |
Why?
|
| Radiation Monitoring | 1 | 1973 | 16 | 0.030 |
Why?
|
| Tic Disorders | 2 | 1984 | 78 | 0.030 |
Why?
|
| Population Growth | 1 | 1993 | 6 | 0.030 |
Why?
|
| Depression | 1 | 2022 | 1339 | 0.020 |
Why?
|
| Fluoroscopy | 1 | 1973 | 99 | 0.020 |
Why?
|
| Radiography, Thoracic | 1 | 1973 | 153 | 0.020 |
Why?
|
| Growth Charts | 1 | 2012 | 15 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2016 | 1572 | 0.020 |
Why?
|
| Decision Trees | 1 | 2012 | 59 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 1993 | 258 | 0.020 |
Why?
|
| Chromatin | 1 | 2016 | 518 | 0.020 |
Why?
|
| Infant Food | 1 | 1992 | 74 | 0.020 |
Why?
|
| Family | 1 | 2016 | 595 | 0.020 |
Why?
|
| Quality Control | 1 | 2012 | 123 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 1439 | 0.020 |
Why?
|
| Comorbidity | 1 | 2017 | 1605 | 0.020 |
Why?
|
| Reference Standards | 1 | 2012 | 242 | 0.020 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 1992 | 93 | 0.020 |
Why?
|
| Guidelines as Topic | 1 | 2012 | 198 | 0.020 |
Why?
|
| Forecasting | 1 | 1993 | 371 | 0.020 |
Why?
|
| Research Design | 2 | 1993 | 742 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2016 | 1233 | 0.020 |
Why?
|
| Kidney | 2 | 1999 | 1330 | 0.020 |
Why?
|
| Executive Function | 1 | 2012 | 126 | 0.020 |
Why?
|
| Nervous System Diseases | 1 | 1995 | 408 | 0.020 |
Why?
|
| Natural History | 1 | 2010 | 1 | 0.020 |
Why?
|
| Adolescent Behavior | 1 | 1993 | 171 | 0.020 |
Why?
|
| Breast Feeding | 1 | 1992 | 233 | 0.020 |
Why?
|
| Lipotropic Agents | 1 | 2010 | 6 | 0.020 |
Why?
|
| DNA Mutational Analysis | 2 | 2005 | 824 | 0.020 |
Why?
|
| Vitamin B Complex | 1 | 2010 | 42 | 0.020 |
Why?
|
| Basal Ganglia Diseases | 1 | 1990 | 25 | 0.020 |
Why?
|
| Charcot-Marie-Tooth Disease | 1 | 1992 | 239 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2015 | 986 | 0.020 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 1 | 2009 | 22 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2014 | 852 | 0.020 |
Why?
|
| Placebos | 1 | 2010 | 234 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 435 | 0.020 |
Why?
|
| Methysergide | 1 | 1989 | 2 | 0.020 |
Why?
|
| Methyltyrosines | 1 | 1989 | 4 | 0.020 |
Why?
|
| Tryptophan Hydroxylase | 1 | 2009 | 33 | 0.020 |
Why?
|
| X Chromosome Inactivation | 1 | 2009 | 64 | 0.020 |
Why?
|
| Genomic Imprinting | 1 | 2010 | 130 | 0.020 |
Why?
|
| Evoked Potentials, Auditory | 2 | 1987 | 52 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2010 | 280 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2012 | 441 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2012 | 488 | 0.020 |
Why?
|
| Genetic Testing | 2 | 2006 | 1098 | 0.020 |
Why?
|
| History, 20th Century | 1 | 2010 | 385 | 0.020 |
Why?
|
| Data Collection | 1 | 2011 | 391 | 0.020 |
Why?
|
| Bradycardia | 2 | 1986 | 60 | 0.020 |
Why?
|
| Family Health | 1 | 2009 | 256 | 0.020 |
Why?
|
| Ammonia | 1 | 1989 | 77 | 0.020 |
Why?
|
| Neurocognitive Disorders | 1 | 1989 | 78 | 0.020 |
Why?
|
| Mortality | 1 | 2010 | 263 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2009 | 327 | 0.020 |
Why?
|
| Survival Rate | 1 | 1993 | 2186 | 0.020 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 1 | 2007 | 93 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 2850 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2007 | 321 | 0.020 |
Why?
|
| Phenobarbital | 1 | 1986 | 32 | 0.020 |
Why?
|
| Electrophysiology | 2 | 2000 | 269 | 0.020 |
Why?
|
| Auditory Perception | 1 | 1987 | 41 | 0.020 |
Why?
|
| Recurrence | 2 | 1989 | 1452 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2007 | 749 | 0.020 |
Why?
|
| Brain Damage, Chronic | 1 | 1985 | 31 | 0.020 |
Why?
|
| Language Disorders | 1 | 2005 | 26 | 0.010 |
Why?
|
| Home Care Services | 1 | 1986 | 75 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2015 | 4751 | 0.010 |
Why?
|
| Chromosome Breakage | 1 | 2005 | 159 | 0.010 |
Why?
|
| Karyotyping | 1 | 2005 | 317 | 0.010 |
Why?
|
| Atrophy | 1 | 1986 | 251 | 0.010 |
Why?
|
| Algorithms | 1 | 1992 | 1719 | 0.010 |
Why?
|
| Bottle Feeding | 1 | 1984 | 39 | 0.010 |
Why?
|
| Time Factors | 1 | 2014 | 6440 | 0.010 |
Why?
|
| Resuscitation | 1 | 1986 | 270 | 0.010 |
Why?
|
| Coma | 1 | 1984 | 57 | 0.010 |
Why?
|
| Community Health Services | 1 | 2005 | 92 | 0.010 |
Why?
|
| Leukemia, Lymphoid | 1 | 1984 | 103 | 0.010 |
Why?
|
| Myelin Basic Protein | 1 | 1984 | 67 | 0.010 |
Why?
|
| Introns | 1 | 2005 | 305 | 0.010 |
Why?
|
| Gonads | 2 | 1973 | 34 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2009 | 2674 | 0.010 |
Why?
|
| Nervous System | 1 | 1984 | 126 | 0.010 |
Why?
|
| Obesity | 1 | 2015 | 2394 | 0.010 |
Why?
|
| Central Nervous System Diseases | 1 | 1984 | 107 | 0.010 |
Why?
|
| Pedigree | 2 | 2000 | 1718 | 0.010 |
Why?
|
| Hypoxia | 1 | 1984 | 258 | 0.010 |
Why?
|
| Sympathetic Fibers, Postganglionic | 1 | 2001 | 5 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 1985 | 1178 | 0.010 |
Why?
|
| Vasoactive Intestinal Peptide | 1 | 2001 | 15 | 0.010 |
Why?
|
| Infant, Premature, Diseases | 1 | 1984 | 252 | 0.010 |
Why?
|
| Catecholamines | 1 | 2001 | 52 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2009 | 3860 | 0.010 |
Why?
|
| Patient Care Team | 1 | 2006 | 572 | 0.010 |
Why?
|
| Base Sequence | 1 | 2005 | 2899 | 0.010 |
Why?
|
| Infant, Premature | 1 | 1986 | 843 | 0.010 |
Why?
|
| COP9 Signalosome Complex | 1 | 2000 | 13 | 0.010 |
Why?
|
| Mesencephalon | 1 | 2000 | 39 | 0.010 |
Why?
|
| Basal Ganglia | 1 | 2000 | 63 | 0.010 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2000 | 109 | 0.010 |
Why?
|
| Frontal Lobe | 1 | 2000 | 117 | 0.010 |
Why?
|
| Thalamus | 1 | 2000 | 88 | 0.010 |
Why?
|
| Peptide Hydrolases | 1 | 2000 | 143 | 0.010 |
Why?
|
| Multiprotein Complexes | 1 | 2000 | 201 | 0.010 |
Why?
|
| Mass Screening | 1 | 2005 | 828 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 1978 | 144 | 0.010 |
Why?
|
| Antibodies | 1 | 2000 | 365 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2001 | 1693 | 0.010 |
Why?
|
| Spleen | 1 | 1999 | 270 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2005 | 1299 | 0.010 |
Why?
|
| Astrocytes | 1 | 2000 | 269 | 0.010 |
Why?
|
| Radiography | 1 | 1978 | 819 | 0.010 |
Why?
|
| Audiometry | 1 | 1996 | 23 | 0.010 |
Why?
|
| Neurologic Examination | 1 | 1996 | 202 | 0.010 |
Why?
|
| Mutation, Missense | 1 | 2000 | 933 | 0.010 |
Why?
|
| Eye Abnormalities | 1 | 1996 | 104 | 0.010 |
Why?
|
| Task Performance and Analysis | 1 | 1995 | 88 | 0.010 |
Why?
|
| Hippocampus | 1 | 2000 | 815 | 0.010 |
Why?
|
| Proteins | 1 | 2000 | 1035 | 0.010 |
Why?
|
| Aging | 1 | 2001 | 1248 | 0.010 |
Why?
|
| Heart | 1 | 1999 | 689 | 0.010 |
Why?
|
| Methods | 1 | 1973 | 126 | 0.010 |
Why?
|
| Lithium | 1 | 1973 | 71 | 0.010 |
Why?
|
| Air Pollution, Radioactive | 1 | 1973 | 2 | 0.010 |
Why?
|
| Mobile Health Units | 1 | 1973 | 26 | 0.010 |
Why?
|
| Cephalometry | 1 | 1993 | 35 | 0.010 |
Why?
|
| Models, Statistical | 1 | 1995 | 491 | 0.010 |
Why?
|
| Head | 1 | 1993 | 115 | 0.010 |
Why?
|
| Neural Conduction | 1 | 1992 | 85 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 1992 | 305 | 0.010 |
Why?
|
| Microcomputers | 1 | 1991 | 13 | 0.010 |
Why?
|
| Liver | 1 | 1999 | 1796 | 0.010 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 1992 | 168 | 0.010 |
Why?
|
| Multigene Family | 1 | 1992 | 305 | 0.010 |
Why?
|
| Remission, Spontaneous | 1 | 1991 | 69 | 0.010 |
Why?
|
| Tomography, Emission-Computed | 1 | 1991 | 37 | 0.010 |
Why?
|
| alpha-Methyltyrosine | 1 | 1989 | 4 | 0.000 |
Why?
|
| Barbiturates | 1 | 1989 | 8 | 0.000 |
Why?
|
| Heart Diseases | 1 | 1994 | 511 | 0.000 |
Why?
|
| Dihydropteridine Reductase | 1 | 1989 | 5 | 0.000 |
Why?
|
| Neopterin | 1 | 1989 | 5 | 0.000 |
Why?
|
| Sex Chromosome Aberrations | 1 | 1989 | 62 | 0.000 |
Why?
|
| Random Allocation | 1 | 1989 | 430 | 0.000 |
Why?
|
| Adrenal Cortex Hormones | 1 | 1991 | 339 | 0.000 |
Why?
|
| DNA | 1 | 1992 | 1472 | 0.000 |
Why?
|
| Methoxyhydroxyphenylglycol | 1 | 1985 | 35 | 0.000 |
Why?
|
| Sural Nerve | 1 | 1985 | 46 | 0.000 |
Why?
|
| Motor Skills | 1 | 1985 | 82 | 0.000 |
Why?
|
| Respiratory Center | 1 | 1984 | 10 | 0.000 |
Why?
|
| Evoked Potentials, Visual | 1 | 1984 | 34 | 0.000 |
Why?
|
| Receptors, Dopamine | 1 | 1984 | 32 | 0.000 |
Why?
|
| Light | 1 | 1984 | 183 | 0.000 |
Why?
|
| Necrosis | 1 | 1984 | 209 | 0.000 |
Why?
|
| Carbon Dioxide | 1 | 1984 | 275 | 0.000 |
Why?
|
| Meningeal Neoplasms | 1 | 1984 | 212 | 0.000 |
Why?
|